Thrombosis Adviser News urn:uuid:866be811-7e6f-2164-41a1-475d023dca6b 2012-05-17T11:17:06+02:00 Thrombosis Adviser News Latest Updates and News on ThrombosisAdviser.com Older women with AF face higher stroke risk than men urn:uuid:d402eb28-9863-67d9-eb02-753e453fe893 2012-05-15T00:00:00+02:00 Venous thromboembolism: EINSTEIN transforms anticoagulant therapy in acute PE urn:uuid:bd23e330-56e3-4114-8e60-9476cc1136e9 2012-05-15T00:00:00+02:00 Aspirin and Warfarin Equally Effective for Most Heart Failure Patients, Study Suggests urn:uuid:b293920d-ef76-4bef-4c60-e29669e51155 2012-05-03T00:00:00+02:00 Warfarin May Be OK for Heart Device Implantation urn:uuid:fd5bfe51-a2aa-383b-924f-1f29b4b8ead9 2012-05-03T00:00:00+02:00 Outpatient Surgery Patients also at Risk urn:uuid:4633c28b-2d3c-9850-7f6c-4e4be1edbb73 2012-05-03T00:00:00+02:00 CHA2DS2-VASc score gives best prediction of stroke risk in AF urn:uuid:b9543605-4fc4-eb5e-eb97-8d5676a6a6c8 2012-04-26T00:00:00+02:00 Single scan could safely rule out pregnancy-related deep vein thrombosis urn:uuid:bff50191-6367-fa39-f111-d39af55ff2a6 2012-04-24T00:00:00+02:00 Additional heparin unnecessary for anticoagulated patients undergoing PCI urn:uuid:2128afa4-9745-9d78-c3f4-9358c7e7a20b 2012-04-24T00:00:00+02:00 Once-daily oral anticoagulant receives positive Common Drug Review recommendation for stroke prevention in atrial fibrillation urn:uuid:b63ffc67-9e75-aff5-48f0-7393e8dd3b72 2012-04-24T00:00:00+02:00 Women don't receive the same treatment as men for heart disease the world-over urn:uuid:161a876b-8bc5-eadb-feb6-f29e97162175 2012-04-24T00:00:00+02:00 Under-Treated Heart Condition That Causes a 500 Percent Increase in the Risk of Stroke Unites Medical and Patient Communities urn:uuid:214e66bf-be54-9db5-a605-ee48c2827633 2012-04-24T00:00:00+02:00 Real-World Experience Reaffirms Bayerâs Rivaroxaban as Effective in Protecting Patients Against Venous Blood Clots urn:uuid:ed58452f-c4ba-9f2c-5d40-73c0ec2aa0b6 2012-04-17T00:00:00+02:00 AF patients admitted to the hospital on weekends have worse outcomes urn:uuid:33ea8c6c-59d3-b5c7-8505-99a889a20c9d 2012-04-13T00:00:00+02:00 Bayer's [...] Rivaroxaban Submitted for EU Marketing Authorisation for the Treatment of Pulmonary Embolism (PE) and Prevention of Recurrent Deep Vein Thrombosis (DVT) and PE urn:uuid:33d1202a-6a3f-4e00-9509-3b5239810d89 2012-04-12T00:00:00+02:00 Cost-Effectiveness of Rivaroxaban in the Prevention of Venous Thromboembolism: A Canadian Analysis using the Ontario Ministry of Health Perspective urn:uuid:c0117a30-c4ac-7862-ad81-3ccbe513a228 2012-04-12T00:00:00+02:00 Infection May Be Trigger for Venous Thromboembolism urn:uuid:f1ea4731-37ed-554d-6fce-5531a3c9f910 2012-04-10T00:00:00+02:00 Elderly Stroke Patients Have High Atrial Fibrillation Prevalence urn:uuid:6a4fbeaa-4eed-63e6-c632-3334cef83ed8 2012-04-10T00:00:00+02:00 New analysis extends dabigatran MI signal to other thrombin inhibitors urn:uuid:3ec1dec6-558a-510f-f765-8db82cfc7dac 2012-04-03T00:00:00+02:00 One-a-day heart pill to stave off stroke is given the green light urn:uuid:c8f5f52a-7309-24c5-ee47-e32460f8e1d5 2012-03-30T00:00:00+02:00 EINSTEIN PE: Rivaroxaban equals standard therapy, halves major bleeding urn:uuid:9ee88add-c717-17dd-b215-85d462d2bea8 2012-03-27T00:00:00+02:00 Dual, triple antiplatelet regimens equal for prevention of blood clots after angioplasty urn:uuid:e334250d-6228-1dc4-8db2-9bf673327fe0 2012-03-27T00:00:00+02:00